Results

Total Results: 1,187 records

Showing results for "weeks".

321. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
     December 31, 2017 - At least 4 weeks study duration after randomization Less than 4 weeks Settings Outpatient and inpatient … • Interviewees are asked about symptoms they have experienced in the past 2 weeks.

322. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
     February 10, 2010 - reactions to therapies • Reduction in/negative influences on quality of life Timing • Minimum of 4 weeks … www.effectivehealthcare.ahrq.gov Published Online: April 25, 2011 Page 9 of 18 Follow-up duration >4 weeks … post intervention < 4 weeks post intervention Sample size N > 10 N < 10 B.

323. Topic Brief: Antenatal Care (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
     April 01, 2021 - Standard practice in the United States consists of monthly antenatal care visits during the first 28 weeks … of pregnancy followed by twice weekly visits until 36 weeks, and weekly visits thereafter.

324. Disposition of Comments Report for Screening, Behavioral Counseling, and Referral in Primary Care To Reduce Alcohol Misuse (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
     July 10, 2012 - 2 sessions…a 2-hour small-group session and a 10 to 20 minute individual tutorial session 2 to 6 weeks … 2 sessions…a 2-hour small-group session and a 10 to 20 minute individual tutorial session 2 to 6 weeks … alcohol use or were some undertaken in settings where the person might have last consumed alcohol some weeks

325. Screening and Diagnosing Gestational Diabetes Mellitus Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
     January 01, 2020 - screening and diagnostic tests, evaluate potential benefits and harms of conventional screening (24 weeks … and beyond) and early testing (<24 weeks), and evaluate the treatment of GDM with regard to changing … pregnant women are screened in the first trimester and get the 2 hour 75 gram glucose test at 24-28 weeks … instead of 55 and 70 and it should be add that a BG target of under 8.0 mmol/l was set at more than 35 weeks … The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational

326. Updating the Framework for Agency for Healthcare Research and Quality’s National Healthcare Quality and Disparities Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-disposition-comments.pdf
     July 11, 2025 - Updating the Framework for Agency for Healthcare Research and Quality’s National Healthcare Quality and Disparities Report Technical Brief Disposition of Comments Report Title: Updating the Framework for Agency for Healthcare Research and Quality’s National Healthcare Quality and Disparities Report …

327. Disposition of Comments_Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-disposition-comments.pdf
     May 01, 2025 - Disposition of Comments_Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review Systematic Review Disposition of Comments Report Title: Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review Draft report available for public comment from March 6, 202…

328. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
     April 01, 2020 - with greater than 1 month of followup after the end of treatment, with most studies involving 6 to 8 weeks … Following this, the peer-reviewed draft report was posted on the AHRQ website for 4 weeks for public … class, included drugs or populations not included here), included very short duration studies (<12 weeks … population (chronic pain with specific conditions), a specific study design (RCTs), and study duration (12 weeks … Restricting to studies of at least 12 weeks’ duration may have limited the evidence for certain treatments

329. White Paper: Living Systematic Reviews: Practical Considerations for Adapting Scope and Communicating the Evolving Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
     June 01, 2025 - scope from only chronic pain (greater than 3 months duration) to also addressing subacute pain (4 weeks … Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks

330. Asthma-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_executive.pdf
     May 01, 2011 - was considered a fatal flaw) • Time until followup (6 months or more was preferable, fewer than 6 weeks … relevant study: N=8 Management of serious acute exacerbation: N=1 No relevant outcomes: N=2 Followup < 4 weeks … meditation.34 This trial reported a 64 percent reduction in symptoms in the intervention group at 12 weeks … and 4-week followup, but the effect was attenuated (yet still statistically significant) after 8 weeks … of interventions to reduce hyperventilation, but only one found group differences at 4, 12, and 26 weeks

331. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - orally, twice daily, had significant improvements in lung function and fewer exacerbations after 24 weeks … declining lung function or who died compared with those outcomes in patients given placebo, after 52 weeks … daily had a significantly smaller decline in lung function than did patients given placebo, after 52 weeks … of 2,403 mg; patients begin with 1 capsule 3 times daily, and titrate to the full dosage after 2 weeks … with IPF were treated with pirfenidone 3 times daily (for a total of 2,403 mg) or placebo for 52 weeks

332. Treating Binge-Eating Disorder. A Review of Evidence for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_consumer.pdf
     May 01, 2016 - and second-generation antidepressants help improve BED in the short term (when taken for 6 to 16 weeks

333. Disposition of Comments: Technical Brief No. 51_Measure Criteria for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measurement-criteria-qdr-disposition-comments.pdf
     April 11, 2025 - Disposition of Comments: Technical Brief No. 51_Measure Criteria for the Agency for Healthcare Research and Quality's National Healthcare Quality and Disparities Report Technical Brief Disposition of Comments Report Title: Measure Criteria for the Agency for Healthcare Research and Quality’s National H…

334. Therapies for Children with Autism Spectrum Disorders (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_consumer.pdf
     September 01, 2014 - The programs can last as long as 12 weeks to 3 years.

335. Living Systematic Review on Plant-Based Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
     March 29, 2023 - KQs: Adults (including pregnant or breastfeeding women) 18 years and older with chronic pain (>12 weeks … Excluded subacute pain Added subacute pain Subacute pain, often defined as pain lasting for 4 to 12 weeks … , represents a transitional state between acute (<4 weeks) pain, which often resolves, and chronic

336. Alcohol-Misuse-Drug-Therapy Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
     February 01, 2016 - Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: � Your doctor* said you have alcohol use disorder and need to stop drinking or cut down the amount you drink. � You have decided to stop or cut down your dri…

337. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
     January 30, 2014 - " $ Current$Literature$Analysis:$ •" A"RCT"compared"CBT"to"supportive"psychotherapy"over"16"weeks"and"found"that"while … March(2012( Assessment:(Current( No$new$information$ A$RCT$(n=77)$compared$CBT$to$SPT$over$16$ weeks … March(2012( Assessment:(Current( No$new$information$ A$RCT$(n=77)$compared$ CBT$to$SPT$over$16$weeks

338. Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
     April 01, 2025 - Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review Systematic Review Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review Executive Summary Main Points • The current body of evidence is derived primarily from racially and ethnically diverse f…

339. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - • Initial dosages range from 2.5 U/kg of body weight 3 times a week to 60 U/kg once every 2 weeks … • 60 U/kg every 2 weeks is the dosage for which the most data are available. … Enzyme replacement therapy for mucopolysaccaridosis VI from 8 weeks of age-a sibling control study … weeks. … weeks.

340. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
     April 01, 2010 - patient with cancer is treated for depression, then response to therapy should be documented within 6 weeks